Company Overview of CoLucid Pharmaceuticals, Inc.
CoLucid Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of central nervous system disorders. Its pipeline includes Lasmiditan, a neurally acting anti-migraine agent that is designed to deliver efficacy in migraine without the vasoconstrictor activity associated with previous generations of migraine therapies; COL-204 for wake promotion; and a Conjugated Stigmines platform that has generated a series of preclinical candidates for the chronic pain, Alzheimer's disease, and psychiatric disorders. CoLucid Pharmaceuticals, Inc. was founded in 2005 and is based in Durham, North Carolina.
2530 Meridian Parkway
Durham, NC 27713
Founded in 2005
Key Executives for CoLucid Pharmaceuticals, Inc.
CoLucid Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|Elan Pharmaceutical Investments Ltd.||United States|
|Checkpoint Genetics||United States|
|Avidity, LLC||United States|
|PEGUS Research, Inc.||United States|
|Shionogi USA, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- Pittsburgh, PA | Research Recruiting AssociationPosted: Apr 10
- Greenfield, IN | Pace Analytical ServicesPosted: May 24
- Raritan, NJ | Johnson & JohnsonPosted: May 25
Sponsored Financial Commentaries
To contact CoLucid Pharmaceuticals, Inc., please visit www.colucid.com. Company data is provided by Capital IQ. Please use this form to report any data issues.